drugset / Trial / NCT03330184

Summary

The aim of this study is to assess the beneficial effects of Bifidobacterium and Berberine Hydrochloride on lowering glucose and delaying progress to diabetes in patients with prediabetes and to detect the potential mechanism.

Timeline

Start
2015-10
Primary completion
2018-04
Completion
2018-04

Drugs

EvaluationDrugModalityDoseRoute
Subject BIFIDOBACTERIUM SPP. Other / unclassified
Subject Berberine Traditional medicine (herbal / TCM)

Indications

No indication recorded.